PROFOUND MEDICAL CORP. Current Derivative Financial Liabilities
PROFOUND MEDICAL CORP. (PROF) had Current Derivative Financial Liabilities of $563.00 thousand as of 2022-12-31, per its 40-F filed 2024-03-07.
Discontinued › Notes
ifrs-full:CurrentDerivativeFinancialLiabilities · last filed 2024-03-07
- 2019-12-31: Current Derivative Financial Liabilities 255.00K CAD; Current Derivative Financial Liabilities as first filed 254.77K CAD.
- 2019-01-01: Current Derivative Financial Liabilities 98.00K CAD.
- 2018-12-31: Current Derivative Financial Liabilities 98.20K CAD.
CAD
| Period end | Current Derivative Financial Liabilities | Current Derivative Financial Liabilities as first filed |
|---|---|---|
| 2019-12-31 | 255.00K CAD 40-F · filed 2021-03-02 | 254.77K CAD 40-F · filed 2020-03-03 |
| 2019-01-01 | 98.00K CAD 40-F · filed 2021-03-02 | |
| 2018-12-31 | 98.20K CAD 40-F · filed 2020-03-03 |
USD
| Period end | Current Derivative Financial Liabilities |
|---|---|
| 2022-12-31 | $563.00K 40-F · filed 2024-03-07 |
| 2021-12-31 | $161.00K 40-F · filed 2023-03-07 |
| 2020-12-31 | $450.00K 40-F · filed 2022-03-03 |
| 2019-12-31 | $196.00K 40-F · filed 2021-03-02 |
| 2019-01-01 | $72.00K 40-F · filed 2021-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |